Gilbert Omenn latest transaction was an Uninformative Buy of $118.31K.
What was Gilbert Omenn's most profitable transaction?
Gilbert Omenn’s most profitable transaction was an Informative Buy of ESPR stock on March 22, 2017. The return on the trade was 80.30%.
What is Gilbert Omenn's role in Galectin Therapeutics?
Gilbert Omenn's role in Galectin Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.